Tango Therapeutics, Inc.

TNGX · Healthcare · Tango Therapeutics, Inc., a precision oncology company, focuses on the discovery and development of drugs in defined patient populations wi…

Tango Therapeutics, Inc. (TNGX), in the Healthcare sector, has 15 disclosed filings on Paydirt over the trailing twelve months from 4 corporate insiders: 0 purchases and 15 sales. Filers took a median of 2 days from execution to disclosure, and the most recent trade was executed Sep 1 and filed Sep 3. The most active filer was Adam Crystal with 11 filings.

Add to watchlist

Filings, ttm

0 buys · 15 sells

Traders, ttm

4 insiders

Volume, ttmiDollar value disclosed in the window

$11.6M

estimated for Congress, as filed for insiders

Median delay

execution to disclosure

Last traded

Sep 1

Filed Sep 3

ADViAverage daily dollar volume

$98.9M

market data

Share price · 12M

$22.52 (+202.3%)

Adjusted for splits and dividends.

Volume by month

Buys $0 Sells $61.7M

Estimated for Congress, as filed for insiders · by filing month · past 24 months

Who filed

Adam Crystal President, R&D 11 filings TL Trv Gp Iv, Llc 10% owner 4 filings BL Boxer Capital Management, LLC Other 3 filings TP Third Rock Ventures GP IV, L.P. 10% owner 2 filings DB

Daniella Beckman Chief Financial Officer 1 filing EL EcoR1 Capital, LLC Director 1 filing BW

Barbara Weber Director, Executive Chair 1 filing

Recent filings

Adam CrystalSALE President, R&D $604K
27,000 sh × $22.37
Exec Sep 1
Filed Sep 3 · 4:01 PM ET Adam CrystalSALE President, R&D $736K
27,000 sh across 2 lots
Exec Aug 3
Filed Aug 5 · 4:01 PM ET Adam CrystalSALE President, R&D $799K
27,000 sh across 2 lots
Exec Jul 1
Filed Jul 2 · 7:23 PM ET Adam CrystalSALE President, R&D $618K
27,000 sh across 2 lots
Exec Jun 1
Filed Jun 3 · 5:30 PM ET Adam CrystalSALE President, R&D $549K
25,900 sh × $21.19
Exec May 1
Filed May 5 · 5:30 PM ET Adam CrystalSALE President, R&D $962K
38,460 sh × $25.00
Exec Apr 15
Filed Apr 16 · 5:30 PM ET Adam CrystalSALE President, R&D $572K
27,000 sh × $21.20
Exec Apr 1
Filed Apr 2 · 5:30 PM ET Adam CrystalSALE President, R&D $241K
12,000 sh × $20.11
Exec Mar 25
Filed Mar 27 · 5:30 PM ET Adam CrystalSALE President, R&D $304K
20,251 sh × $15.00
Exec Mar 5
Filed Mar 9 · 5:30 PM ET Adam CrystalSALE President, R&D $694K
54,345 sh × $12.77
Exec Feb 25
Filed Feb 27 · 5:30 PM ET Adam CrystalSALE President, R&D $224K
18,251 sh × $12.26
Exec Feb 3
Filed Feb 4 · 5:30 PM ET Barbara WeberSALE Director, Executive Chair $370K
30,186 sh × $12.26
Exec Feb 3
Filed Feb 4 · 5:30 PM ET Daniella BeckmanSALE Chief Financial Officer $125K
10,204 sh × $12.26
Exec Feb 3
Filed Feb 4 · 5:30 PM ET Trv Gp Iv, LlcSALE 10% owner $4.8M
477,401 sh × $10.15
Exec Oct 23 2025
Filed Oct 27 2025 · 5:30 PM ET Trv Gp Iv, LlcSALE 10% owner $4.0M
500,000 sh × $8.02
Exec Sep 25 2025
Filed Sep 29 2025 · 5:30 PM ET Trv Gp Iv, LlcSALE 10% owner $2.6M
363,541 sh × $7.04
Exec Sep 16 2025
Filed Sep 17 2025 · 5:30 PM ET Trv Gp Iv, LlcSALE 10% owner $5.1M
729,365 sh across 2 lots
Exec Sep 5 2025
Filed Sep 9 2025 · 5:30 PM ET Third Rock Ventures GP IV, L.P.SALE 10% owner $2.1M
302,194 sh × $7.00
Exec Aug 22 2025
Filed Aug 26 2025 · 5:30 PM ET Third Rock Ventures GP IV, L.P.SALE 10% owner $7.7M
1,100,000 sh × $7.01
Exec Aug 19 2025
Filed Aug 21 2025 · 5:30 PM ET EcoR1 Capital, LLCSALE 10% owner $8.4M
2,700,000 sh across 3 lots
Exec Nov 6 2024
Filed Nov 8 2024 · 5:30 PM ET Boxer Capital Management, LLCSALE Other $9.7M
3,080,000 sh × $3.14
Exec Nov 6 2024
Filed Nov 7 2024 · 5:30 PM ET Boxer Capital Management, LLCSALE Other $4.3M
633,000 sh × $6.87
Exec Oct 25 2024
Filed Oct 28 2024 · 5:30 PM ET Boxer Capital Management, LLCSALE Other $6.1M
875,000 sh across 2 lots
Exec Oct 21 2024
Filed Oct 23 2024 · 5:30 PM ET Trv Gp Iv, LlcSALE 10% owner $710K
67,400 sh × $10.53
Exec Sep 13 2024
Filed Sep 17 2024 · 5:30 PM ET Trv Gp Iv, LlcSALE 10% owner $867K
75,000 sh × $11.56
Exec Sep 5 2024
Filed Sep 9 2024 · 5:30 PM ET